Find Academic Supervisors

Brenda Schulman is a Professor and Director of the Molecular Machines and Signaling Pathways department at the Max Planck Institute of Biochemistry in Martinsried, Germany. She also holds an honorary professorship at the Technical University of Munich's Department of Chemistry and serves as Adjunct Faculty at St. Jude Children's Research Hospital in Memphis, TN, USA. Her research focuses on understanding how ubiquitin and ubiquitin-like proteins regulate cellular processes through protein modification. Dr. Schulman's research interests center on structural biology of the ubiquitin-proteasome system and ubiquitin-like proteins. Her work has shown that hundreds of dynamic multiprotein complexes are transiently converted into different conformations by specialized regulatory factors that control ubiquitin and ubiquitin-like proteins, thereby monitoring virtually all processes in cell biology. She combines biochemical reconstitution, structural analysis, enzymology, protein design, cell biology, and genetics to understand how these molecular machines function. Her research has significant implications for understanding diseases such as cancer, neurodegenerative disorders, and viral infections where defects in ubiquitin pathways are implicated. Her extensive publication record demonstrates expertise in ubiquitin signaling, protein degradation mechanisms, structural biology of E3 ligases, and molecular machines. Her work spans from fundamental mechanisms of ubiquitin chain formation to therapeutic applications in targeted protein degradation. Among her numerous scientific accolades are the Feldberg Prize for Anglo-German Scientific Exchange (2025), ERC Advanced Grant (2023), Louis-Jeantet Prize for Medicine (2023), Gottfried Wilhelm Leibniz Prize (2019), and election to the National Academy of Sciences (2014). She has also received the Dorothy Crowfoot Hodgkin Award from The Protein Society and has been an Investigator of the Howard Hughes Medical Institute. Dr. Schulman leads an active research group that has produced numerous high-impact publications in top journals including Nature, Cell, and Nature Structural & Molecular Biology. Her team has made significant contributions to understanding the structural mechanisms of ubiquitin transfer, E3 ligase specificity, and the role of ubiquitin in cellular quality control pathways. Current research in her lab focuses on deciphering the ubiquitin code and developing novel approaches for targeted protein degradation.

• Structural biology
• Ubiquitin-proteasome system
• Ubiquitin-like proteins
• +5 more

Dr. Wolfgang Zachariae is a Group Leader at the Max Planck Institute of Biochemistry in Martinsried, Germany, where he heads the "Chromosome Biology" research group. His laboratory focuses on understanding the molecular mechanisms of meiosis, particularly chromosome segregation and the role of cohesin in this process. Dr. Zachariae's educational background includes: PhD (summa cum laude) from Heinrich-Heine University, Düsseldorf, Germany (1990-1994), with Prof. Karin Breunig on "Regulation of the transcriptional activator Lac9" Diploma Thesis with Prof. Karin Breunig on "Enrichment of the transcription factor Lac9 from the yeast Kluyveromyces lactis" (1988-1990) Studies in Biology at Heinrich-Heine University, Düsseldorf, Germany (1984-1988) Postdoctoral Fellowship at the Institute of Molecular Pathology (IMP), Vienna, Austria (1994-1999), in the Laboratory of Prof. Kim Nasmyth, focusing on "cell cycle control by the anaphase-promoting complex in budding yeast" Dr. Zachariae's research focuses on the molecular biology of chromosome segregation during meiosis. His group uses baker's yeast as a model organism to study how chromosomes are correctly separated during the two meiotic divisions. A key focus is on cohesin, a molecular "glue" that holds chromosome pairs together, and how its regulated destruction ensures proper chromosome separation. His research employs diverse methodologies including genetics, biochemistry, video microscopy, and computational simulations of biochemical reactions. This work has significant medical relevance as errors in meiotic chromosome segregation are leading causes of infertility, miscarriage, and chromosome abnormalities like Down syndrome. Analysis of Dr. Zachariae's recent publications reveals a consistent focus on the molecular mechanisms of meiosis, particularly the regulation of cohesin and the anaphase-promoting complex (APC/C). His work spans from fundamental molecular mechanisms (such as phosphorylation of Rec8 by casein kinase) to the broader implications for gamete formation and chromosome segregation. The research demonstrates an interdisciplinary approach combining yeast genetics with advanced biochemical and imaging techniques. Dr. Zachariae has made significant contributions to the field of chromosome biology through his publications in top-tier journals including Cell, EMBO Journal, Developmental Cell, and Current Biology. His work on the regulation of meiotic chromosome segregation has provided fundamental insights into cell division processes that are conserved across eukaryotes. Dr. Zachariae leads an active research group consisting of PhD students (Nikoleta Milanovic, Addison E. Noronha, Vinal Massaad, Magdalena Matijevic), postdoctoral researchers (Olha Biriuk, Oleksii Lyzak, Marc Llavanera, Tugce Öz-Yoldas), and technical staff. His laboratory investigates the molecular mechanisms of chromosome segregation during meiosis using baker's yeast as a model system. The group has developed sophisticated approaches combining genetics, biochemistry, live-cell imaging, and computational modeling to understand how cohesin is regulated during the two meiotic divisions.

• Chromosome Biology
• Meiosis
• Cell Division
• +4 more

Stefan Irniger serves as a faculty member at a German-speaking academic institution, where he has supervised numerous doctoral candidates between 2004 and 2014. His academic position as a Privatdozent (PD) indicates he has completed the habilitation process, the highest academic qualification in the German system. Dr. Irniger's research spans multiple areas of molecular and cellular biology, with particular emphasis on: Microbial pathogenesis and host-pathogen interactions Fungal and yeast molecular genetics Protein regulation and post-translational modifications Enzyme structure and function Cellular metabolism and signaling pathways His doctoral students have published work examining diverse biological systems including Toxoplasma gondii, Saccharomyces cerevisiae, Aspergillus nidulans, and various plant-pathogen interactions. The publications demonstrate a consistent focus on molecular mechanisms underlying cellular processes, with particular attention to protein regulation, metabolic pathways, and host-microbe interactions. His students' work appears across multiple subdisciplines including parasitology, fungal genetics, enzymology, and membrane biology. Dr. Irniger has guided 18 doctoral students to completion, with dissertation topics spanning from 2004-2014. His students have investigated fundamental biological questions with implications for infectious disease, agricultural pathology, and basic cellular mechanisms. While specific awards are not documented in the available records, the breadth and quality of supervised research indicates significant scholarly contribution to his fields of expertise.

• Molecular Biology
• Microbiology
• Biochemistry
• +4 more

Prof. Dr. Claus Schwechheimer is a Professor of Plant Systems Biology at the Technical University of Munich (TUM), leading the Chair of Plant Systems Biology within the TUM School of Life Sciences. His research focuses on plant growth regulation, particularly auxin and gibberellin signaling pathways, using Arabidopsis thaliana as a model organism. He combines molecular, genetic, and cell biological approaches with proteomics and genomics to study protein degradation and hormone-mediated processes. Key roles include serving as Spokesperson for the DFG Collaborative Research Center 924 (2011–2023) and coordinating DFG Priority Programs. He holds a PhD from the University of East Anglia and postdoctoral experience at Yale University. Notable awards include the Nirit and Michael Shaoul Fellowship (2015) and a DFG research grant (1999–2001). His work involves investigating auxin transport activation by D6PK kinases, gibberellin signaling via B-GATA transcription factors, and proteomic analysis of plant development. The lab collaborates on projects like the Arabidopsis proteome draft and explores applications in crop plants such as barley and tomatoes. Grants include leadership in SFB924 and participation in Priority Programs. The lab hosts junior researchers like Dr. Philipp Denninger and collaborates with international institutions. Research spans plant stress responses, protein localization, and genetic regulation of developmental processes.

• Plant Systems Biology
• Plant Hormone Signaling (Auxin, Gibberellin)
• Protein Kinase Regulation
• +3 more

Dr. Desiree Loreth is a Research Fellow at the Institute of Cellular and Integrative Physiology within the University Medical Center Hamburg-Eppendorf . Her work spans molecular mechanisms in kidney physiology, neurodegenerative diseases, and cancer metastasis. Research Interests include: Proteasome function in glomerular cells and podocytes Role of UCH-L1 enzyme in mitochondrial dynamics Neuroimmunological mechanisms in autoimmune kidney diseases Neurodegenerative pathways in Alzheimer's disease models Metastasis biology in non-small cell lung cancer Publication Trends show expertise in proteasome regulation, ubiquitin pathways, neurodegenerative imaging, and metastasis modeling. Collaborations with Prof. Christine Meyer-Schwesinger and Prof. Martin Meyer-Luehmann highlight interdisciplinary approaches. Advising & Collaborations involve co-authoring 15+ publications with teams across nephrology, neuroscience, and oncology.

• Molecular Biology
• Nephrology
• Neuroscience
• +4 more

Regina Ensenauer is a Professor of Experimental Pediatrics and Metabolism at Heinrich Heine University Düsseldorf, affiliated with the University Children’s Hospital. Her research focuses on early-life origins of childhood obesity, fetal programming, and metabolic disease prevention. She leads the PEACHES cohort study investigating maternal obesity’s long-term effects on offspring. As an Anna Boyksen Fellow at the TUM Institute for Advanced Study, her work addresses preventive pediatrics. Her academic journey includes a medical degree from Heidelberg University, residency in Pediatrics at Freiburg, and postdoctoral training at the Mayo Clinic. Awards include the Friedrich-Linneweh Award (2012) and Mayo Alumni Scientific Award (2005). Her research spans metabolite profiling, placental metabolism, and nutritional interventions, with emphasis on translational strategies to combat obesity. Key publications address insulin resistance in maternal obesity, fatty acid metabolism in pregnancy, and neurodevelopmental impacts of dietary PUFAs. Her work integrates clinical, molecular, and epidemiological approaches to understand obesity’s developmental origins, aiming to inform preventive public health policies.

• Early origins of childhood obesity
• Fetal programming
• Nutrient-sensing mechanisms
• +3 more

Dr. Lina Herhaus holds dual roles as a Research Group Leader at the Helmholtz Centre for Infection Research (HZI) and a W1 Professor at Hannover Medical School (MHH). Her research focuses on immune signaling, autophagy, and molecular mechanisms underlying immune pathways. She leads the "Immune Signaling" group at HZI, funded by the MICROSTAR Program, and has prior leadership at Goethe University Frankfurt (2020–2024) and the Frankfurt Cancer Institute (2019–2020). Education: PhD in Biochemistry and Cell Signaling (2014) – MRC, University of Dundee Double Degree in Molecular Biology and Applied Biology (First-Class Honors, 2010) – Hochschule Bonn-Rhein-Sieg and University of Dundee Early research at ECOSUR, Mexico (2006–2007) Research Interests: Immune signaling pathways Autophagy regulation and its role in disease Molecular mechanisms of bacterial pathogenesis Host-pathogen interactions in Salmonella and HCMV infections Therapeutic targeting of autophagy pathways Awards: Signal Transduction Society (STS) Science Award (2024) AIM Council of International Rising Stars (2024) Tim Hunt Prize for Cell Biology (2013) Grants & Leadership: Lead HZI’s Immune Signaling Group since 2024 Previously led Immune Signaling Group at Goethe University (2020–2024) Funded by MICROSTAR Program (HZI) and MHH Labs/Teams: Immune Signaling Group at HZI Campus, collaborating on autophagy, immune pathways, and infectious disease research.

• Immune Signaling
• Autophagy
• Cell Signaling
• +3 more

Prof. Dr. Sandra Pohl is a full Professor at the University Medical Center Hamburg-Eppendorf (UKE), affiliated with the Department of Osteology and Biomechanics. Her research focuses on lysosomal storage disorders, particularly mucolipidosis types II and III, and their systemic effects on bone, cartilage, kidney and the central nervous system. She employs mouse models, human genetic studies and translational approaches to dissect disease mechanisms and develop therapeutic strategies. Education & Training No specific educational details provided in the source material; only the academic title "Prof. Dr. (PhD)" is listed. Research Interests Prof. Pohl’s work centers on: Molecular pathology of mucolipidosis type II (I-cell disease) and type III (pseudo-Hurler polydystrophy). GlcNAc-1-phosphotransferase biology and its role in lysosomal enzyme targeting. Skeletal manifestations of lysosomal storage disorders, including osteopenia, cartilage degeneration and dysostosis multiplex. Neurocognitive outcomes and CNS imaging in mucolipidosis patients. Enzyme replacement therapy design and evaluation in pre-clinical mouse models. Proteostasis, autophagy and ubiquitin-proteasome system interactions in disease pathogenesis. Publication Trends Between 2020 and 2024, Prof. Pohl has published extensively on the intersection of lysosomal dysfunction and skeletal/renal/neurological pathology. Her recent articles emphasize: Genotype–phenotype correlations in GNPTAB/GNPTG variants. Translational mouse models recapitulating human mucolipidosis. Multi-omics profiling (proteomics, imaging, metabolomics) to uncover disease biomarkers. Interdisciplinary studies linking basic cell biology to clinical manifestations. Research Support & Collaborations Prof. Pohl currently leads or co-leads the following initiatives: SFB 877, Teilprojekt B03: “Proteolysis-ver” (exact title abbreviated in source) – a collaborative research center funded by the German Research Foundation (DFG). Cross-institutional consortia involving nephrologists, neurologists, geneticists and imaging specialists across Germany and internationally. Laboratory & Core Facilities Her team utilizes state-of-the-art core facilities provided by UKE, including: Transgenic mouse core Advanced imaging and microscopy Mass-spectrometry-based proteomics High-throughput sequencing and bioinformatics platforms

• Lysosomal storage disorders
• Mucolipidosis type II and III
• Osteogenesis imperfecta
• +5 more

Dana Branzei is a Professor and head of the Department of Biological and Genomic Treatment Approaches at the Research Center One Health within the Faculty of Biology at the University of Duisburg-Essen. She leads a research group investigating DNA repair mechanisms and genome stability. Her work focuses on how cells repair DNA damage, tolerate replication stress, and maintain chromosome integrity through processes integrated with DNA replication machinery (replisome). Her research interests center on molecular mechanisms of DNA damage tolerance, replication fork dynamics, chromosome cohesion, and the role of protein complexes like SMC5/6 in maintaining genome stability. Key areas include error-free DNA repair pathways, SUMOylation in DNA transactions, and the molecular basis of cancer predisposition linked to replication defects. Recent publications (2020-2023) demonstrate strong focus on replication fork protection mechanisms, chromatin remodeling during repair, helicase functions in recombination, and structural analyses of repair complexes. Research consistently bridges fundamental chromosome biology with clinical applications in cancer and neurodegenerative diseases. Scientific Awards: Alexander von Humboldt Professorship (2025) EMBO Membership (2016) FIS grant by Italian Ministry of University and Research (2023) She leads an active research team including postdoctoral fellows, PhD candidates, and master's students. Current lab members focus on replication stress responses, chromatin dynamics, and repair pathway coordination. The laboratory collaborates extensively within the University Alliance Ruhr network.

• DNA Repair
• Genome Stability
• Replication Stress
• +3 more

Manfred Jücker is a Professor at the Institute of Biochemistry and Signal Transduction within the University Medical Center Hamburg-Eppendorf (UKE) . His research focuses on phosphoinositide signaling pathways , particularly the PI3K/AKT/mTOR network , and their roles in cancer progression and leukemia pathogenesis . Jücker investigates how Akt isoforms differentially regulate metastasis , drug resistance , and cell survival in tumors like hepatocellular carcinoma , breast cancer , and colorectal cancer . Recent publications highlight his work on SHIP1 phosphatase in hematopoietic malignancies , targeted kinase inhibition in AML , and metabolic reprogramming via AKT isoform regulation . His team uses in vitro tumor models , xenotransplantation , and phosphoproteomics to explore novel therapeutic approaches. Jücker collaborates extensively with clinicians and researchers in oncology , immunology , and translational medicine , contributing to drug development strategies and personalized cancer therapy . Key projects include reducing animal experiments through in vitro tumoroids and analyzing CYTL1 as a treatment target in elderly AML patients.

• Signal Transduction
• Oncology
• Biochemistry
• +5 more

Lucie Carrier is a Professor at the Institute of Experimental Pharmacology and Toxicology , University Medical Center Hamburg-Eppendorf. She leads a research group focusing on cardiomyopathy mechanisms , particularly involving sarcomere proteins like cardiac myosin-binding protein C (MyBP-C) and their role in hypertrophic cardiomyopathy (HCM) . Her work explores ubiquitin-proteasome system dysfunction, autophagy , and gene therapy approaches for HCM. Key collaborators include Thomas Eschenhagen and Sandra Schlossarek . Research Interests : Sarcomere mutations, proteasome inhibition, RNA editing, cardiac remodeling, iPSC models, and microRNA regulation in HCM. Grants & Projects : Multiple studies on Mybpc3 -targeted mouse models, iPSC-derived cardiomyocytes, and pharmacological interventions (e.g., nebivolol, sacubitril/valsartan). Key Contributions : Discoveries about MyBP-C phosphorylation , ANKRD1 mutations , and tubulin detyrosination as therapeutic targets. She co-authored guidelines for autophagy assays and ESC consensus documents. Scientific Awards : No explicit awards mentioned in the text.

• Cardiovascular Research
• Cardiomyopathy
• Gene Therapy
• +3 more

Prof. Dr. F.-Ulrich Hartl is the Director of the Department of Cellular Biochemistry at the Max Planck Institute of Biochemistry in Martinsried, Germany. His research focuses on molecular chaperones, protein folding, proteostasis maintenance, and mechanisms linking protein aggregation to aging and neurodegenerative diseases like Alzheimer's, Parkinson's, and Huntington's. Education: MD, University of Heidelberg (1982) Dr.med., University of Munich (1985) Dr.med.habil., University of Munich (1990) Research Interests: Hartl's work investigates how molecular chaperones (e.g., chaperonins) facilitate protein folding and prevent toxic aggregation. His team explores age-dependent proteostasis collapse and develops strategies to counteract neurodegenerative pathologies. Recent studies highlight chaperone roles in amyloid formation, biomolecular condensates, and autophagy regulation. Scientific Awards: 2023 Schleiden Medal 2022 Nakasone Award 2019 Breakthrough Prize in Life Sciences 2011 Lasker Award for Basic Medical Research 2002 Gottfried Wilhelm Leibniz Prize 2000 Foreign Honorary Member, American Academy of Arts and Sciences Over 20 additional major awards (1985–2023) Advising: Hartl mentors 14 PhD students and collaborates with group leaders like Dr. Roman Körner (mass spectrometry) and Dr. Sae-Hun Park (protein folding). His lab emphasizes interdisciplinary approaches combining structural biology, proteomics, and neurodegenerative disease modeling.

• Molecular Chaperones
• Protein Folding
• Protein Homeostasis (Proteostasis)
• +2 more

Dr. Julian D. Langer serves as Group Leader and Head of Mass Spectrometry at the Max Planck Institute of Biophysics and Max Planck Institute for Brain Research in Frankfurt. His laboratory specializes in developing advanced mass spectrometry workflows and methods to address complex questions in structural biology, molecular neurobiology, and membrane protein research. Funded by both Max Planck Institutes, his lab operates eight state-of-the-art instruments from Bruker, Thermo, and Waters coupled to nano-UPLCs and analytical UPLCs. Dr. Langer's research focuses on three primary areas: direct sequencing of membrane protein complexes, hydrogen/deuterium exchange mass spectrometry (HDX-MS) for studying membrane protein dynamics, and proteome profiling in neuronal systems. His group has made significant contributions to identifying novel subunits in membrane protein complexes, characterizing ligand binding sites, and monitoring proteome remodeling in homeostatic synaptic plasticity. He is particularly known for developing specialized MALDI-TOF/TOF techniques that allow acquisition of information-rich PSD MS/MS spectra up to m/z 9000. His recent work demonstrates significant trends toward neuroproteomics and small protein discovery , with numerous publications on synaptic proteome mapping, neuronal ribosome dynamics, and detection of novel small proteins in prokaryotes. His research bridges structural biology, neurobiology, and analytical chemistry, with applications spanning from basic membrane protein mechanisms to neurological disorders. Dr. Langer actively collaborates with numerous research groups and is a member of DFG's SPP 2002 (Small proteins in prokaryotes) and BMBF's MOEL-SOEL program. He has developed specialized methodologies including BONCAT technology for proteome turnover studies and workflows for cell-type specific proteome analysis from living animals. His laboratory maintains strong connections with instrument vendors and has successfully extended HDX-MS techniques to large membrane protein complexes. Current research directions include investigating protein synthesis in neuronal processes, characterizing molecular components in specialized cellular systems like Sepia chromatophores, and developing next-generation mass spectrometry approaches for biomolecular analysis.

• Mass Spectrometry
• Structural Biology
• Proteomics
• +5 more

Prof. Dr. Robert Ernst is a leading researcher at the Center for Molecular Signaling (PZMS) , Saarland University, where he heads the Medical Biochemistry & Molecular Biology group. His work focuses on understanding how biological membranes maintain their identity and functionality through dynamic protein-lipid interactions, with particular emphasis on endoplasmic reticulum (ER) stress response and membrane homeostasis. Academic appointments: Professor , Saarland University Key research areas: Membrane biogenesis, Lipid metabolism, Protein folding stress, Cellular adaptation mechanisms Funding: ERC Consolidator Grant (MemDense project), SFB 1027 , Volkswagen Foundation Prof. Ernst's laboratory employs interdisciplinary approaches combining genetics, biochemistry, biophysics, and computational modeling to investigate membrane property sensors that control organelle identity and cellular resilience during stress, aging, and metabolic diseases. Scientific contributions include discovering novel mechanisms of lipid bilayer stress sensing via transmembrane domains (e.g., IRE1, PERK), establishing homeoviscous adaptation in eukaryotes, and developing innovative technologies like MemPrep for organellar membrane isolation. His work has significant implications for type II diabetes, neurodegenerative disorders, and secretory cell pathologies. Current research directions explore how membrane protein crowding and aberrant lipid compositions trigger chronic ER stress, aiming to develop membrane-targeted therapies for metabolic diseases. Training : Leads a vibrant research team with multiple PhD and MD students, including Jona Causemann , Aamna Jain , Alexandra Cogan , Konstancja Porzycka , and Sören Eggers .

• Membrane Cell Biology
• Biochemistry
• Biophysics
• +6 more

Prof. Dr. Markus Kaiser is a Professor of Chemical Biology at the University of Duisburg-Essen since 2010. He leads the Chemical Biology group at the Center of Medical Biotechnology (ZMB) , focusing on regulated proteolysis and bioactive small molecule mechanisms. University of Duisburg-Essen Center of Medical Biotechnology (ZMB) Faculty of Biology His research integrates chemical biology approaches with drug discovery , targeting proteases like HTRA1 and DPP8/9 for therapeutic applications in diabetes , cancer , and infectious diseases . Recent work explores chaperone complexes, plant-pathogen interactions, and tuberculosis treatments. The 2024-2025 publications highlight expertise in enzyme inhibition , targeted protein degradation , and pathogen manipulation across human and plant systems. These studies span journals like Nature Structural & Molecular Biology , Nature Communications , and Cell . Scientific Awards include: ERC Starting Grant (2011) Forschungspreis der Engelhornstiftung (2011) Marie Curie Postdoctoral Stipendium (2004-2005) Friedrich Weygand Prize (2003) He collaborates with national and international teams on projects like the EFRE/JTF ClearView project for AMD treatment strategies and participates in the DFG CRC 1430 on cell state transitions. His lab includes scientific coworkers (e.g., Dr. Farnusch Kaschani) and technical assistants (e.g., Leonard Sewald).

• Regulated proteolysis
• Chemical biology approaches
• Bioactive small molecule action
• +3 more